Brief: Renuvion Receives FDA Clearance For Specific Use After Liposuction
02/05/2023 12:35
May 2 (Reuters) - Apyx Medical Corp APYX.O :
* RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER
LIPOSUCTION
Source text for Eikon: ID:nPn82pcVDa
Further company coverage: APYX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apyx Medical
See all newsBrief: Apyx Medical - Appoints Stavros Vizirgianakis As Executive Chairman Effective June 11, 2026
Brief: Apyx Medical Corporation Receives Expanded FDA 510(K) Clearance Adding Power Liposuction Capability To AYON Body Contouring System™
Apyx Medical Q1 revenue beats estimates, outlook raised
Preview: Weight-loss revolution sparks new appetite for aesthetics firms
Apyx Medical Q4 revenue beats on Surgical Aesthetics unit strength